Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV multicenter study of Shezhishenhuang ointment for eczema
ChiCTR1900021089Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Apr 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of shezhishenhuang ointment in atopic dermatitis (AD), sponsored by Beijing Friendship Hospital. Primary endpoint: Eczema Area and Severity Index. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
shezhishenhuang ointment
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR1900021089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021089.